Viewing Study NCT04535895


Ignite Creation Date: 2025-12-24 @ 1:38 PM
Ignite Modification Date: 2026-01-03 @ 8:21 PM
Study NCT ID: NCT04535895
Status: WITHDRAWN
Last Update Posted: 2022-10-12
First Post: 2020-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Simultaneous Integrated Boost Technique in Breast Cancer Radiotherapy
Sponsor: Medical University of Graz
Organization:

Study Overview

Official Title: Simultaneous Integrated Boost (SIB) Technique in the Adjuvant Radiotherapy of Breast Cancer Patients.
Status: WITHDRAWN
Status Verified Date: 2022-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Treatment standard has changed
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Adjuvant radiotherapy after breast conserving surgery has been shown to improve both local control and overall survival. Dose escalation of the tumor bed by addition of a boost after whole breast radiotherapy reduces the risk of local recurrence in invasive breast cancer.

Simultaneous integrated boost (SIB) techniques have been shown to provide more conformal treatment plans than conventional sequential boost, in addition, SIB enables a reduction in the overall treatment time by 1 week compared to conventional boost techniques.

The proposed study is aimed at evaluating radiation-induced toxicity in patients treated with breast-conserving surgery in combination with radiotherapy using SIB technique.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: